Roadshow Announcement: Billion-Dollar Golden Track – Life Science Tools Special Investment Roadshow Now Recruiting!

With the booming global life sciences sector, the gradual convergence of artificial intelligence, big data, and life sciences, coupled with the implementation of the Biosecurity Law of the People's Republic of China, the biotechnology industry is poised to usher in unprecedented development opportunities, thereby creating significant business prospects for the life sciences tools industry.

Despite the broader economic headwinds and the impact of government centralized procurement on the healthcare industry this year, which have led many to believe that a “winter” has arrived, the life sciences tools sector—often regarded as the “shovel seller” in the healthcare gold rush—is on the verge of explosive growth. The life sciences tools industry provides equipment, reagents, consumables, and related services to biopharmaceutical companies, medical diagnostics firms, research laboratories, and other application areas. With its wide-ranging and comprehensive scope, it plays a crucial supporting role in enhancing the efficiency and speed of scientific research. As the pace of localization accelerates, an increasing number of Chinese life sciences tools companies are coming into the public spotlight, signaling that the golden age of China’s life sciences tools industry has truly arrived.

In this context,VCBeat Select, in collaboration with Xingong Tairong, Hosts the VCBeat Select Investment and Financing Roadshow Series [Life Science Tools Special Session], collaborate with multiple stakeholders to jointly explore the market potential and future development trends of the life sciences tools industry, comprehensively empowering its rapid growth, promote cooperation between upstream and downstream industries.

Aoyin Biotech, Dongkang Biotech, Chen'an Biotech,PanGen Medicine,Hezhuo Biotechnology, Kaigen Biotechnology,Yuce Bio,Yuanguji, Yikang Medicine,Administered MicroorganismsRoadshow presentations by executives of life sciences tools companies, showcasing the latest achievements in the field of life sciences tools.

Legend Capital, Huangpu Medical Fund, Shuimu Ventures, CDH Investments, Junxin Capital, Huatai Securities, Yida Capital, CPE YuanfengHeads of more than 20 investment institutions attended the event, engaging in in-depth discussions with pitching companies to explore the frontiers of life sciences investment.

Tuesday, September 26, 2023, 14:00

Nanjing Xingong Tairong Biological Reagent Industry Cluster

(Lecture Hall, 2nd Floor, Building 18, No. 767 Dixiu Road, Binjiang Development Zone, Jiangning District, Nanjing)

Event Registration:This event will be held as an offline roadshow, with attendance limited to 80 participants.

Registration Method: https://hdxu.cn/o8jU4Or scan the QR code above to register.

The Xin Gong Tai Rong Biological Reagent Industry Cluster is a key provincial and municipal engineering project, jointly invested by Nanjing Xin Gong Investment Group and Nanjing Jiangning Binjiang Development Zone, and professionally operated through market-oriented mechanisms by technology enterprises. It serves as an industrial landmark project focused on the technological frontier. Centered on the new pharmaceutical and life health industries, the project establishes a shared Contract Manufacturing Organization (CMO) platform to break the constraints of traditional closed-loop manufacturing and address the "Darwinian trap" in the commercialization of scientific achievements. It aims to provide global bioreagent technology companies with an internationalized, high-end, clustered, and shared manufacturing model, offering integrated services across the entire industry value chain—from product development to distribution—and creating a smart biological reagent industrial park characterized by "commonality, sharing, co-creation, and win-win cooperation."

The project has a total planned area of 200,000 square meters. Phase I covers a construction area of 135,000 square meters, including approximately 60,000 square meters for manufacturing facilities, 20,000 square meters for R&D and testing, 6,000 square meters for third-party warehousing, and 15,000 square meters for shared supporting amenities. It is designed to attract 30–50 domestic and international technology companies and facilitate the implementation of 80 industrialization projects.

Founded in 2014, VCBeat is a novel industry service provider that leverages data as its foundation, research as its core, and brand media as its connector to facilitate the precise aggregation of industrial resources and accelerate the growth of industry innovators. It offers services such as brand communication, research consulting, data monitoring, and resource/project matchmaking to enterprises, government industrial parks, investment institutions, and other entities within the industry chain.

A service under VCBeat dedicated to integrating brand building with performance-driven marketing and conversion, featuring programs and events such as “Open Courses,” “New Product Showcases,” and “Government-Enterprise Exchange Forums.” Leveraging VCBeat’s reachable network of 300,000 professionals in the innovative healthcare sector, it helps enterprises rapidly promote innovative products and services and precisely identify potential target partners through rigorous topic and product selection, professional content planning, and precise, effective outreach.